Sigma Labs, Inc. Warrant
SGLBW
SGLBW was delisted on the 17th of February, 2022.
2 hedge funds and large institutions have $9K invested in Sigma Labs, Inc. Warrant in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
61% less capital invested
Capital invested by funds: $23K → $9K (-$14K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$551 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $9K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| – | +$551 | +1,490 | +187% |
|
SGLBW Hedge Fund Activity: Q1 2020 in Review
2 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Sigma Labs, Inc. Warrant (SGLBW) for Q1 2020, worth a combined $9K — down 61% from $23K a quarter earlier.
Fund positioning in SGLBW was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $551.
- 2 institutional investors held Sigma Labs, Inc. Warrant (SGLBW) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $9K of Sigma Labs, Inc. Warrant stock for Q1 2020, down 61% quarter-over-quarter.
- 0 funds opened new Sigma Labs, Inc. Warrant positions in Q1 2020 and 0 closed out.
- The largest Sigma Labs, Inc. Warrant buyer in Q1 2020 was UBS Group, an estimated $551 added.
Based on aggregated 13F filings for Q1 2020.